– Sant Cugat del Vallés 12/04/2018.
The UDIC has been awarded the prize for the best team of those participating in the Mission trial. This study, developed at the General University Hospital of Catalonia, evaluates the efficacy and safety of an oral anti-amyloid medication in mild Alzheimer’s disease. It is awarded by the company Syneos Health, after evaluating all the participating centers in Spain, after reviewing the quality of the data, the number of patients included and the agility in the procedures.
